Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.31
+0.33 (4.73%)
Nov 22, 2024, 4:00 PM EST - Market closed
Lifecore Biomedical Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$10.00
Upside
+36.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +36.80% | Nov 22, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +9.44% | Sep 5, 2024 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 28, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +36.80% | Sep 1, 2023 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +23.12% | Sep 1, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +50.48% | Jun 2, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +36.80% | May 24, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +9.44% | Mar 21, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +9.44% | Mar 20, 2023 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $11 → $2 | Buy → Hold | Downgrades | $11 → $2 | -72.64% | Mar 20, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +50.48% | Mar 17, 2023 |